Is a complete SHA/688617 research report available?

Question

Accepted Answer

No complete published report is available for sha/688617 (SHA/688617) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Volume
Market cap	30.1B
Revenue (ttm)	2.7B
Net income (ttm)	866.9M
EPS (ttm)	CN¥6.13
Shares out	141.1M
P/E (trailing)	34.8x
P/E (forward)	30.2x
Dividend	CN¥1.00 (0.48%)

Metric	Value
Country	China
Country code	CN
Employees	3,118
Employees Change	563%
Employees Change Percent	22.04
Enterprise value	CNY 28.8B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Medical Devices
Industry PE	35.73
Industry PE Fwd	23.78
Isin	CNE100004C45
Last refreshed	2026-07-29
Market cap	CNY 30.1B
Price	CNY 216
Price currency	CNY
Rev Per Employee	873,550.01x
Sector	Healthcare
Sector PE	39.51
Sector PE Fwd	22.32
Sic	3841
Symbol	sha/688617
Website	https://www.aptmed.com

Metric	Value
Earnings Yield	2.88%
EV Earnings	33.25x
EV/EBIT	30.52x
EV/EBITDA	27.19x
EV/FCF	41.05x
EV/Sales	10.58x
FCF yield	2.34%
Forward P/E	30.24x
P/B ratio	10x
P/E ratio	34.76x
P/S ratio	11.04x
PE Ratio3 Y	51.22x
PE Ratio5 Y	63.01x

Metric	Value
EBIT Margin	34.68%
EBITDA Margin	38.58%
FCF margin	25.78%
Gross margin	72.48%
Gross Profit	CNY 2B
Gross Profit Growth	25.7%
Gross Profit Growth Q	23.65%
Gross Profit Growth3 Y	28.8%
Gross Profit Growth5 Y	37.5%
Net Income	CNY 866.9M
Net Income Growth	21.05%
Net Income Growth Q	25.27%
Net Income Growth Quarters	23%
Net Income Growth Years	7%
Net Income Growth3 Y	30.08%
Net Income Growth5 Y	42.18%
Pretax Margin	36.27%
Profit Margin	31.83%
Profit Per Employee	CNY 278,038
Profitable Quarters	CNY 27
Profitable Years	9
ROA	17.96
Roa5y	13.13
ROCE	30.78
ROE	29.72
Roe5y	24.35
ROIC	48.48
Roic5y	49.92

Metric	Value
Cagr1y	-25.45%
Cagr3y	8.19%
Cagr5y	4.09%
Div CAGR3	8.41%
EPS Growth	20.97
EPS Growth Q	25.39
EPS Growth Quarters	17
EPS Growth Years	7
EPS Growth3 Y	30.26
EPS Growth5 Y	35.23
FCF Growth	235.96%
FCF Growth Q	18.79%
FCF Growth3 Y	38.1%
FCF Growth5 Y	38.32%
OCF Growth	24.87%
OCF Growth Q	15.32%
OCF Growth3 Y	33.53%
OCF Growth5 Y	37.81%
Revenue Growth	25.24x
Revenue Growth Q	24.78x
Revenue Growth Quarters	23x
Revenue Growth Years	8x
Revenue Growth3 Y	27.95x
Revenue Growth5 Y	36.8x

SHA/688617 (SHA/688617)

Coverage state: Market snapshot only — no published research

Generate the first SHA/688617 analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · SHA/688617

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHA/688617 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on SHA/688617

Frequently asked questions

Metric	Value
Asset Turnover	CNY 0.83
Assets	CNY 3.4B
Cash	CNY 1.3B
Current Assets	CNY 1.9B
Current Liabilities	CNY 361.9M
Debt	CNY 14.5M
Debt EBITDA	CNY 0.01
Debt Equity	CNY 0
Debt FCF	CNY 0.02
Equity	CNY 3B
Interest Coverage	1,158.8
Liabilities	CNY 423.4M
Long Term Assets	CNY 1.5B
Long Term Liabilities	CNY 61.5M
Net Cash	CNY 1.3B
Net Cash By Market Cap	CNY 4.25
Net Cash Growth	7.82%
Net Debt EBITDA	CNY -1.21
Net Debt Equity	CNY -0.42
Net Debt FCF	CNY -1.82
Tangible Book Value	CNY 2.5B
Tangible Book Value Per Share	CNY 18.11
WACC	2

Metric	Value
Current ratio	5.2
Inventory Turnover	1.67
Net Working Capital	CNY 237.6M
Quick ratio	3.74
Working Capital	CNY 1.5B
Working Capital Turnover	CNY 1.88

Metric	Value
Buyback Yield	-0.07%
Dividend Growth	-42.86%
Dividend Growth Years	4%
Dividend per share	CNY 1
Dividend Years	6
Dividend Yield	0.48%
Ex Div Date	2026-05-14
Last Dividend	CNY 1
Payout Frequency	Annual
Payout Ratio	19.64%

Metric	Value
1Y total return	-25.44%
200-day SMA	242.1
3Y total return	26.65%
50-day SMA	202.9
50-day SMA vs 200-day SMA	50under200
5Y total return	22.17%
All Time High	337.2
All Time High Change	-36.82%
All Time High Date	2025-10-24
All Time Low	67.05
All Time Low Change	217.72%
All Time Low Date	2022-04-27
ATR	10.73
Beta	-0.41
Beta1y	0.02
Beta2y	0.11
Ch YTD	-12.43
High	218.5
High52	337.2
High52 Date	2025-10-24
High52ch	-36.03%
Low	213
Low52	176.3
Low52 Date	2026-06-29
Low52ch	22.36%
Ma50ch	4.98%
Price vs 200-day SMA	-12.02%
RSI	55.6
RSI Monthly	45.77
RSI Weekly	44.17
Sharpe ratio	-0.75x
Sortino ratio	-0.93
Total Return	0.41%
Tr YTD	-12.07
Tr1m	17.52%
Tr1w	-0.77%
Tr3m	-14%

Metric	Value
Analyst Count	8
Analyst Ratings	Strong Buy
Operating Income	CNY 944.5M
Operating Income Growth	22.64
Operating Income Growth Q	27.19
Operating Income Growth3 Y	31.73
Operating Income Growth5 Y	46.5
Operating margin	34.68
Price target	CNY 321
Price Target Change	CNY 48.8

Metric	Value
Float	75,421,644%
Net Borrowing	3,981,695
Shares Insiders	20.04%
Shares Institutions	30.04%
Shares Out	141,126,186
Shares Qo Q	-0.83%
Shares Yo Y	0.07%

Metric	Value
Average Volume	2,111,422.1x
Bv Per Share	21.22
CAPEX	CNY -291M
Ch1m	17.52
Ch1w	-0.77
Ch1y	-25.75
Ch3m	-14.35
Ch3y	25.04
Ch5y	19.44
Ch6m	-12.19
Change	1.25%
Change From Open	1.03
Close	213
Days Gap	0.22
Depreciation Amortization	106,246,125
Dollar Volume	57,273,742.5
Earnings Date	2026-08-20
EBIT	CNY 944.5M
EBITDA	CNY 1.1B
EPS	CNY 6.13
F Score	7
FCF	CNY 702.3M
FCF EV Yield	2.44x
FCF Per Share	CNY 4.98
Financing CF	-627,561,239
Fiscal Year End	December
Founded	2,002
Goodwill	48,133,117
Graham Number	54.09647
Graham Upside	-74.61
Income Tax	CNY 134.6M
Investing CF	-575,340,398
Is Primary Listing	1
Last Earnings Date	2026-04-24
Last Report Date	2026-03-31
Last Split Date	2025-06-19
Last Split Type	Forward
Lynch Fair Value	CNY 153
Lynch Upside	-28.08
Ma150	229.7
Ma150ch	-7.26%
Ma20	203.9
Ma20ch	4.48%
Net CF	-221,074,536
Next Earnings Date	2026-08-20
Open	213.5
P FCF Ratio	42.81
P OCF Ratio	30.27
Payment Date	2026-05-14
Position In Range	49.09
Ppne	863,305,099
Price Date	2026-07-29
Price EBITDA	CNY 28.61
Ptbv Ratio	11.86
Relative Volume	0.13x
Revenue	2,723,728,946x
Tax By Revenue	4.94x
Tax Rate	13.63%
Tr6m	-11.82%
Volume	265,525
Z Score	57.94